SethBFurgesonMD

PubMed

• Assessing Cognition in Chronic Kidney Disease Using the NIH Toolbox®.
  Alexander Zhang, Allison Shapiro, Zhiying You, Ester Oh, Seth Furgeson, Petter Bjornstad, Kalie L Tommerdahl, Angelina Dixon, Erin Stenson, Jessica Kendrick> ;Kidney360. 2024 Apr 3
• Acute and Chronic Kidney Disease Worsen Outcomes in Experimental Sepsis.
  Floyd, D., Colbert, J., Feng, F., Furgeson, S., Montford, J.> ;Kidney360. 2024 Feb 14
• 2 citations
  Immune checkpoint activity regulates polycystic kidney disease progression.
  Emily K Kleczko, Dustin T Nguyen, Kenneth H Marsh, Colin D Bauer, Amy S Li, Marie-Louise T Monaghan, Michael D Berger, Seth B Furgeson, Berenice Y Gitomer, Michel B Ch...> ;JCI Insight. 2023 Jun 22
• Leukotriene Antagonist Use is Associated With Lower Systolic Blood Pressure in Adults.
  Jennifer Lai, Seth Furgeson, Petter Bjornstad, Zhiying You, Kalie L Tommerdahl, Jessica Kendrick> ;Kidney International Reports. 2023 Feb 1
• Chlorthalidone and Advanced Chronic Kidney Disease.
  Seth B Furgeson, Stuart Linas> ;Clinical Journal of the American Society of Nephrology. 2022 Jul 1
• 6 citations
  15-Lipoxygenase worsens renal fibrosis, inflammation, and metabolism in a murine model of ureteral obstruction.
  John R Montford, Colin Bauer, Jeremy Rahkola, Julie A Reisz, Deanna Floyd, Katharina Hopp, Danielle E Soranno, Jelena Klawitter, Mary C M Weiser-Evans, Raphael Nemenof...> ;American Journal of Physiology. Renal Physiology. 2022 Jan 1
• 5 citations
  Internal Medicine Residents' Perceptions of Nephrology as a Career: A Focus Group Study.
  Natalie Beck, Seth Furgeson, Michel Chonchol, Jessica Kendrick> ;Kidney360. 2020 Oct 29
• 23 citations
  PTEN (Phosphatase and Tensin Homolog) Protects Against Ang II (Angiotensin II)-Induced Pathological Vascular Fibrosis and Remodeling-Brief Report.
  Sizhao Lu, Keith A. Strand, Marie F Mutryn, Rebecca M. Tucker, Austin J Jolly, Seth B. Furgeson, Karen S. Moulton, Raphael A. Nemenoff, Mary C.M. Weiser-Evans> ;Arteriosclerosis, Thrombosis, and Vascular Biology. 2020 Feb 1
• 10 citations
  Inhibition of 5-lipoxygenase decreases renal fibrosis and progression of chronic kidney disease
  John R. Montford, Colin D. Bauer, Evgenia Dobrinskikh, Katharina Hopp, Moshe Levi, Mary C.M. Weiser-Evans, Raphael A. Nemenoff, Seth B. Furgeson> ;American Journal of Physiology. Renal Physiology. 2019 Apr 1
• 41 citations
  CD8+ T cells modulate autosomal dominant polycystic kidney disease progression
  Emily K. Kleczko, Kenneth H. Marsh, Logan C. Tyler, Seth B. Furgeson, Bonnie L. Bullock, Christopher Altmann, Makoto Miyazaki, Berenice Gitomer, Peter C. Harris, Mary ...> ;Kidney International. 2018 Dec 1
• 28 citations
  PTEN deficiency promotes pathological vascular remodeling of human coronary arteries
  Karen S. Moulton, Marcella Li, Keith A. Strand, Shawna Burgett, Penn McClatchey, Rebecca M. Tucker, Seth B. Furgeson, Sizhao Lu, Bruce E. Kirkpatrick, Joseph C. Clevel...> ;JCI Insight. 2018 Feb 22
• 5 citations
  Bone marrow-derived cPLA2α contributes to renal fibrosis progression
  John R. Montford, Allison M.B. Lehman, Colin D. Bauer, Jelena Klawitter, Jost Klawitter, Joanna M. Poczobutt, Micah S. Scobey, Mary C.M. Weiser-Evans, Raphael A. Nemen...> ;Journal of Lipid Research. 2017 Dec 11
• 21 citations
  A new CTGF target in renal fibrosis.
  John R. Montford, Seth B. Furgeson> ;Kidney International. 2017 Oct 1
• 5 citations
  Cytosolic phospholipase A2α increases proliferation and de-differentiation of human renal tubular epithelial cells.
  John R. Montford, Allison M.B. Lehman, Micah S. Scobey, Mary C.M. Weiser-Evans, Raphael A. Nemenoff, Seth B. Furgeson> ;Prostaglandins & Other Lipid Mediators. 2016 Aug 21
• 29 citations
  Characterizing fibrosis in UUO mice model using multiparametric analysis of phasor distribution from FLIM images
  Suman Ranjit, Alexander Dvornikov, Moshe Levi, Seth B. Furgeson, Enrico Gratton> ;Biomedical Optics Express. 2016 Sep 1
• 49 citations
  Label-free fluorescence lifetime and second harmonic generation imaging microscopy improves quantification of experimental renal fibrosis
  Suman Ranjit, Evgenia Dobrinskikh, John R. Montford, Alexander Dvornikov, Allison M.B. Lehman, David J. Orlicky, Raphael A. Nemenoff, Enrico Gratton, Moshe Levi, Seth ...> ;Kidney International. 2016 Nov 1
• 10 citations
  Activation of the Retinoid X Receptor Modulates Angiotensin II-Induced Smooth Muscle Gene Expression and Inflammation in Vascular Smooth Muscle Cells
  Allison M.B. Lehman, John R. Montford, Henrick Horita, Allison C. Ostriker, Mary C.M. Weiser-Evans, Raphael A. Nemenoff, Seth B. Furgeson> ;Molecular Pharmacology. 2014 Nov 1
• 32 citations
  Selective Inactivation of PTEN in Smooth Muscle Cells Synergizes With Hypoxia to Induce Severe Pulmonary Hypertension
  Henrick Horita, Seth B. Furgeson, Allison C. Ostriker, Kyle A. Olszewski, Timothy M. Sullivan, Leah R. Villegas, Michelle Levine, Jane E. Parr, Carlyne D. Cool, Raphae...> ;Journal of the American Heart Association. 2013 Jun 18
• Basically, Dialysis Is Not Good Enough
  Seth B. Furgeson, Isaac Teitelbaum> ;Clinical Journal of the American Society of Nephrology. 2013 Feb 1
• 26 citations
  Serum response factor regulates expression of phosphatase and tensin homolog through a microRNA network in vascular smooth muscle cells.
  Henrick Horita, Peter A. Simpson, Allison C. Ostriker, Seth B. Furgeson, Vicki Van Putten, Mary C.M. Weiser-Evans, Raphael A. Nemenoff> ;Arteriosclerosis, Thrombosis, and Vascular Biology. 2011 Dec 1
• 104 citations
  SDF-1α Induction in Mature Smooth Muscle Cells by Inactivation of PTEN Is a Critical Mediator of Exacerbated Injury-Induced Neointima Formation
  Raphael A. Nemenoff, Henrick Horita, Allison C. Ostriker, Seth B. Furgeson, Peter A. Simpson, Vicki VanPutten, Joseph T. Crossno, Stefan Offermanns, Mary C.M. Weiser-E...> ;Arteriosclerosis, Thrombosis, and Vascular Biology. 2011 Jun 1
• 65 citations
  Mechanisms of Type I and Type II Pseudohypoaldosteronism
  Seth B. Furgeson, Stuart L. Linas> ;Journal of the American Society of Nephrology. 2010 Nov 1
• 74 citations
  Inactivation of the tumour suppressor, PTEN, in smooth muscle promotes a pro-inflammatory phenotype and enhances neointima formation
  Seth B. Furgeson, Peter A. Simpson, Insun Park, Vicki VanPutten, Henrick Horita, Christopher D. Kontos, Raphael A. Nemenoff, Mary C.M. Weiser-Evans> ;Cardiovascular Research. 2010 May 1
• 2 citations
  New treatment options and protocols for peritoneal dialysis-related peritonitis.
  Seth B. Furgeson, Isaac Teitelbaum> ;Contributions to Nephrology. 2009 Jan 1
• 88 citations
  Targeted Deletion of PTEN in Smooth Muscle Cells Results in Vascular Remodeling and Recruitment of Progenitor Cells Through Induction of Stromal Cell–Derived Factor-1α
  Raphael A. Nemenoff, Peter A. Simpson, Seth B. Furgeson, Nihal Kaplan-Albuquerque, Joseph T. Crossno, Pamela J. Garl, James K. Cooper, Mary C.M. Weiser-Evans> ;Circulation Research. 2008 May 9
• Join now to see all